BH
ANGO icon

Broadfin Holdings’s AngioDynamics ANGO Stock Holding History

Broadfin Holdings’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7M Sell
1,818,533
-250,800
-12% -$2.85M 100% 1
2026
Q1 		$23.5M Buy
+2,069,333
New +$22.4M 100% 1

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Broadfin Holdings's ANGO Position: Q2 2026 in Review

Broadfin Holdings reduced its AngioDynamics (ANGO) stake by 12% in Q2 2026, selling an estimated $2.85M and leaving 1,818,533 shares worth $23.7M. The position accounts for 100% of the portfolio, ranked #1.

Broadfin Holdings first reported a position in ANGO in Q1 2026 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Broadfin Holdings held 1,818,533 shares of AngioDynamics worth $23.7M as of Q2 2026.
  • Broadfin Holdings sold 250,800 AngioDynamics shares in Q2 2026, an estimated $2.85M.
  • AngioDynamics made up 100% of Broadfin Holdings's portfolio in Q2 2026, its #1 holding.
  • Broadfin Holdings first reported a position in AngioDynamics in Q1 2026 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Broadfin Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.